Candida norvegensis is an emerging fluconazole- resistant pathogen isolated in most cases from skin and mucous membranes of immunocompromized patients. Documented invasive candidiasis (IC) due to C. norvegensis has been rarely reported, thus the clinical features of patients at risk for this pathogen are poorly defined. We report a liver transplant patient who developed IC due to C. norvegensis and review other cases of C. norvegensis IC published in the literature.
|Number of pages||3|
|Journal||Infectious Disease Reports|
|Publication status||Published - 2014|
ASJC Scopus subject areas
- Infectious Diseases